今世缘 reported revenue of ¥6.44B for the period ended 2026-06-30, -7.4% year on year. Net income was ¥2.08B, a 32.3% net margin on a 74.1% gross margin. The largest revenue line is 特A+类 at 58% of the total. Free cash flow for the period was ¥-0.66B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥6.44B | -7.4% |
| Gross profit | ¥4.77B | — |
| Operating income | ¥2.79B | — |
| Net income | ¥2.08B | -6.6% |
| Gross margin | 74.1% | Net margin 32.3% |
| Revenue Q/Q | -51.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 特A+类 | ¥3.74B | 58.2% |
| 特A类 | ¥2.31B | 35.8% |
| A类 | ¥0.18B | 2.8% |
| 其他 | ¥0.10B | 1.5% |
| B类 | ¥0.08B | 1.2% |
| C类、D类 | ¥0.03B | 0.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.66B | 25.9% |
| R&D | ¥0.03B | 0.4% |
| SG&A | ¥1.12B | 17.4% |
| Tax & other | ¥0.71B | 11.0% |
| Item | Amount |
|---|---|
| Total assets | ¥25.87B |
| Total liabilities | ¥8.73B |
| Shareholders' equity | ¥17.15B |
| Equity / assets | 66.3% |
| Operating cash flow | ¥-0.50B |
| Capital expenditure | ¥0.16B |
| Free cash flow | ¥-0.66B |
| Cash conversion (OCF / net income) | 78% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
万泰生物 ・ 豪威集团 ・ 华友钴业 ・ 瑞芯微 ・ 兆易创新 ・ 洛阳钼业 ・ 德业股份 ・ 东鹏饮料 ・ 澜起科技 ・ 中国通号 ・ 中微公司 ・ 传音控股
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies